Product Information

LEVOTHYROXINE 137 MCG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0627 per EA under NDC 33342040011. Its NADAC has been published 125 times since Apr 3, 2024.

FDA first approved this application on Dec 21, 2022. Its Orange Book therapeutic-equivalence code is AB1,AB2,AB3,AB4 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVOTHYROXINE 137 MCG TABLET

LEVOTHYROXINE SODIUM
$0.0627per EA

Strength

137 ug/1

NDC

33342040011

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LEVOTHYROXINE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA211417

FDA Approved

12/21/2022

TE Code

AB1,AB2,AB3,AB4

On Market Since

12/21/2022

Pharmacological Classes

Thyroxine
l-Thyroxine

Price Statistics

The NADAC for LEVOTHYROXINE 137 MCG TABLET has been published 125 times since Apr 3, 2024, and over the history we have for it it has declined 27.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0627 per EA
All-time high$0.0881 (Jul 10, 2024)
All-time low$0.0555 (Jul 17, 2024)
52-week high$0.0755
52-week low$0.0624
Median price$0.0736
Average price$0.0727
Largest weekly change+51.0% (Jun 19, 2024)
Weeks tracked125
Tracking sinceApr 3, 2024

Price History

1W

+0.6%

1M

-0.3%

3M

-2.4%

6M

-10.6%

1Y

-15.0%

3Y

N/A

5Y

N/A

All

-27.5%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LEVOTHYROXINE 137 MCG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 137 MCG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.0627 per EA (NDC 33342040011), effective Aug 19, 2026.

How has the price of LEVOTHYROXINE 137 MCG TABLET changed over time?

Over the history we have for it, the NADAC for LEVOTHYROXINE 137 MCG TABLET has declined 27.5%. It has been tracked across 125 weekly CMS publications since Apr 3, 2024.

What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 137 MCG TABLET?

Since Apr 3, 2024, the NADAC for LEVOTHYROXINE 137 MCG TABLET has ranged from a low of $0.0555 (Jul 17, 2024) to a high of $0.0881 (Jul 10, 2024), with a median of $0.0736 per EA.

Are there cheaper alternatives to LEVOTHYROXINE 137 MCG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVOTHYROXINE 137 MCG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LEVOTHYROXINE 137 MCG TABLET?

LEVOTHYROXINE 137 MCG TABLET (NDC 33342040011) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.